Announcements Trials
Browse Landscape

Phase

Phase 2 142Phase 1 35Phase NA 20Phase 1/2 19Phase 4 5Phase 3 5Phase 2/3 3Phase EARLY_PHASE1 2

Status

Completed 3Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 37OTHER 5NIH 2

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Carcinoma, Renal Cell 4Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1 1Kidney Neoplasms 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Sunitinib × Clear all
NCT06726421 2026-01-15

STROKER

Sun Yat-sen University

Phase 3 Recruiting
252 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04394975 2025-11-28

Study to Evaluate the Efficacy and Safety of Toripalimab in Combination With Axitinib Versus Sunitinib Monotherapy in Advanced Renal Cell Cancer

Shanghai Junshi Bioscience Co., Ltd.

Phase 3 Completed
421 enrolled
Genitourinary

Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1

NCT07165418 2025-09-10

A Comparison of Vorolanib Tablets Combined With Everolimus Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed After Treatment With Immunotherapy Monotherapy or in Combination With TKI

Peking University Cancer Hospital & Institute

Phase 3 Not yet recruiting
116 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00930033 2025-09-05

CARMENA

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed
452 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00732914 2014-04-23

Sequential Study to Treat Renal Cell Carcinoma

Sponsor GmbH

Phase 3 Completed
272 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡